Successful treatment of chronic knee pain following localization by a sigma-1 receptor radioligand and PET/MRI: a case report
Peter William Cipriano, Sheen-Woo Lee, Daehyun Yoon, Bin Shen, Vivianne Lily Tawfik, Catherine Mills Curtin, Jason L Dragoo, Michelle Louise James, Christopher Robert McCurdy, Frederick Te-Ning Chin, Sandip Biswal, Peter William Cipriano, Sheen-Woo Lee, Daehyun Yoon, Bin Shen, Vivianne Lily Tawfik, Catherine Mills Curtin, Jason L Dragoo, Michelle Louise James, Christopher Robert McCurdy, Frederick Te-Ning Chin, Sandip Biswal
Abstract
Background: The ability to accurately diagnose and objectively localize pain generators in chronic pain sufferers remains a major clinical challenge since assessment relies on subjective patient complaints and relatively non-specific diagnostic tools. Developments in clinical molecular imaging, including advances in imaging technology and radiotracer design, have afforded the opportunity to identify tissues involved in pain generation based on their pro-nociceptive condition. The sigma-1 receptor (S1R) is a pro-nociceptive receptor upregulated in painful, inflamed tissues, and it can be imaged using the highly specific radioligand 18F-FTC-146 with PET.
Case presentation: A 50-year-old woman with a 7-year history of refractory, left-knee pain of unknown origin was referred to our pain management team. Over the past several years, she had undergone multiple treatments, including a lateral retinacular release, radiofrequency ablation of a peripheral nerve, and physical therapy. While certain treatments provided partial relief, her pain would inevitably return to its original state. Using simultaneous positron emission tomography/magnetic resonance imaging (PET/MRI) with the novel radiotracer 18F-FTC-146, imaging showed increased focal uptake of 18F-FTC-146 in the intercondylar notch, corresponding to an irregular but equivocal lesion identified in the simultaneously acquired MRI. These imaging results prompted surgical removal of the lesion, which upon resection was identified as an inflamed, intraarticular synovial lipoma. Removal of the lesion relieved the patient's pain, and to date the pain has not recurred.
Conclusion: We present a case of chronic, debilitating knee pain that resolved with surgery following identification of the pathology with a novel clinical molecular imaging approach that detects chronic pain generators at the molecular and cellular level. This approach has the potential to identify and localize pain-associated pathology in a variety of chronic pain syndromes.
Keywords: 18F-FTC-146; PET/MRI; chronic pain; intraarticular synovial lipoma; knee pain; molecular imaging; sigma-1 receptor.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
- Zamanillo D, Romero L, Merlos M, Vela JM. Sigma 1 receptor: a new therapeutic target for pain. Eur J Pharmacol. 2013;716(1-3):78–93.
- Shen B, Behera D, James ML, et al. Visualizing nerve injury in a neuropathic pain model with [18F]FTC-146 PET/MRI. Theranostics. 2017;7(11):2794–2805.
- James ML, Shen B, Nielsen CH, et al. Evaluation of σ-1 receptor radioligand 18F-FTC-146 in rats and squirrel monkeys using PET. J Nucl Med. 2014;55(1):147–153.
- Shen B, James ML, Andrews L, et al. Further validation to support clinical translation of [(18)F]FTC-146 for imaging sigma-1 receptors. EJNMMI Res. 2015;5(1):49.
- Hjørnevik T, Cipriano PW, Shen B, et al. Biodistribution and radiation dosimetry of 18F-FTC-146 in humans. J Nucl Med. 2017;58(12):2004–2009.
- Hill JA, Martin WR, Milgram JW. Unusual arthroscopic knee lesions: case report of an intra-articular lipoma. J Natl Med Assoc. 1993;85(9):697–699.
- Hirasawa Y, Okajima S, Ohta M, Tokioka T. Nerve distribution to the human knee joint: anatomical and immunohistochemical study. Int Orthop. 2000;24(1):1–4.
- Monnet FP. Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance. Biol Cell. 2005;97(12):873–883.
- Tejada MA, Montilla-García A, Sánchez-Fernández C, et al. Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors. Psychopharmacology. 2014;231(19):3855–3869.
Source: PubMed